Which has grown faster, EDIT or OVID?

Neither grew: over the past five years both shrank revenue, with EDIT's decline the smaller — EDIT at a -10.34% CAGR versus OVID at -62.76%.

How have EDIT and OVID total returns compared?

Over the past 5 years, EDIT delivered -40.76% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.

Editas Medicine, Inc. (EDIT) vs Ovid Therapeutics Inc. (OVID)

A side-by-side comparison of Editas Medicine, Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EDIT

Editas Medicine, Inc.

$435M

$2.83HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

OVID

Ovid Therapeutics Inc.

$447M

$2.40HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — EDIT vs OVID

growth of $100 · dividends reinvested · last 9y

EDIT -85.3% (-19.2%/yr)OVID -80.9% (-16.8%/yr)OVID compounded faster over this window

EDIT OVID

EDIT vs OVID: by the numbers

•OVID is the larger company ($447M vs $435M market cap).
•Both run net losses; EDIT's is the smaller (-157.32% vs -2178.90% net margin).
•Both shrank revenue over the past five years; EDIT's decline was smaller (-10.34% vs -62.76% CAGR).

Metrics side by side

Valuation

Metric	EDIT	OVID
P/S ratio	9.25	282.38
P/B ratio	4.13	2.13

Profitability

Metric	EDIT	OVID
Gross margin	100.00%	100.00%
Operating margin	-245.15%	-585.20%
Net margin	-157.32%	-2178.90%
ROE	-70.24%	-16.43%
ROIC	-48.61%	-26.29%

Growth (annualized)

Metric	EDIT	OVID
Revenue CAGR (5Y)	-10.34%	-62.76%
Total return CAGR (5Y)	-40.76%	-6.98%

Frequently asked

Which has grown faster, EDIT or OVID?: Neither grew: over the past five years both shrank revenue, with EDIT's decline the smaller — EDIT at a -10.34% CAGR versus OVID at -62.76%.
How have EDIT and OVID total returns compared?: Over the past 5 years, EDIT delivered -40.76% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EDIT analysis Full OVID analysis Interactive comparison tool

Dig into the metrics

Editas Medicine ROE Ovid Therapeutics ROE Editas Medicine operating margin Ovid Therapeutics operating margin Editas Medicine revenue growth Ovid Therapeutics revenue growth Editas Medicine free cash flow Ovid Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.